5-Carbamoyl imidazoles
    61.
    发明授权
    5-Carbamoyl imidazoles 失效
    5-氨基甲酰咪唑

    公开(公告)号:US4260774A

    公开(公告)日:1981-04-07

    申请号:US51741

    申请日:1979-06-25

    IPC分类号: C07D233/90

    CPC分类号: C07D233/90

    摘要: There are provided compounds of the formula: ##STR1## wherein R is an adamantyl group, or a phenyl group unsubstituted or substituted with a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a halogen atom, a nitro group, a cyano group, a methylenedioxy group or an acetamido group, useful as anti-transplanted-tumor agents and immunosuppressants.

    摘要翻译: 提供下式的化合物:其中R是金刚烷基,或未取代或被低级烷基,低级烷氧基,低级烷硫基,卤原子,硝基, 氰基,亚甲二氧基或乙酰氨基,可用作抗移植肿瘤剂和免疫抑制剂。

    Imidazo- and pyrimido[2,1-b]quinazolines and preparation thereof
    62.
    发明授权
    Imidazo- and pyrimido[2,1-b]quinazolines and preparation thereof 失效
    咪唑并嘧啶并[2,3-b]喹唑啉及其制备方法

    公开(公告)号:US4179560A

    公开(公告)日:1979-12-18

    申请号:US553676

    申请日:1975-02-27

    CPC分类号: C07D487/04

    摘要: Imidazo- and pyrimido[2,1-b]quinazolines of the formula, ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen, halogen, trifluoromethyl, nitro, C.sub.1-4 alkyl or C.sub.1-4 alkoxy, or R.sub.1 and R.sub.2 may together represent methylenedioxy; R.sub.3 is hydrogen, C.sub.1-4 alkyl, phenyl or substituted phenyl of the formula, ##STR2## (wherein R is halogen, C.sub.1-4 alkyl or C.sub.1-4 alkoxy); R.sub.4 is hydrogen, C.sub.1-4 alkyl or aralkyl; and A is C.sub.2-3 alkylene wich may be optionally substituted by one or two C.sub.1-2 alkyl radicals, and pharmaceutically acceptable acid addition salts thereof, are prepared by reacting a compound of the formula, ##STR3## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined above; and X is oxygen or sulfur, with a halogenating agent at a temperature of about 30.degree. C. to about 180.degree. C. In the above imidaxo- and pyrimido[2,1-b]quinazolines, those having C.sub.1-4 alkyl, or ##STR4## as R.sub.3 are novel compounds and show antidepressant and/or antihypertensive activities.

    摘要翻译: 其中R 1和R 2独立地为氢,卤素,三氟甲基,硝基,C 1-4烷基或C 1-4烷氧基,或者R 1和R 2可以一起代表下式的咪唑并 - 嘧啶并[2,3-b]喹唑啉, 亚甲二氧基; R 3是氢,C 1-4烷基,苯基或下式的取代的苯基,其中R是卤素,C 1-4烷基或C 1-4烷氧基; R4是氢,C1-4烷基或芳烷基; 并且A是可以任选被一个或两个C 1-2烷基取代的C 2-3亚烷基及其药学上可接受的酸加成盐,其通过使下式化合物,其中R1,R2,R3, R4和A如上所定义; 在上述酰胺基 - 和嘧啶并[2,1-b]喹唑啉中,具有C 1-4烷基的那些,或其中X是氧或硫,与卤化剂在约30℃至约180℃的温度下反应。 作为R3是新化合物并显示抗抑郁药和/或抗高血压活性的图像。

    .gamma.-Piperidinobutyrophenones
    63.
    发明授权
    .gamma.-Piperidinobutyrophenones 失效
    {65-哌啶基丁酰苯

    公开(公告)号:US4148796A

    公开(公告)日:1979-04-10

    申请号:US388561

    申请日:1973-08-15

    CPC分类号: C07D401/06 C07D211/48

    摘要: Novel .gamma.-piperidinobutyrophenone derivatives of the formula, ##STR1## wherein R.sup.1 is halogen, amino, alkanoylamino, alkylamino or N-(alkanoyl)alkylamino;R.sup.2 is hydrogen or halogen, provided that when R.sup.1 is halogen, R.sup.2 must be halogen; andZ is a piperidino group having the formula (A), ##STR2## (wherein each of R.sub.a and R.sub.b is hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl; R.sup.3 is hydrogen or hydroxyl; and n is 1 or 2), or a piperidino group having the formula (B), ##STR3## (wherein R.sub.c is hydrogen or lower alkyl; and each of R.sub.d and R.sub.e is hydrogen, halogen, lower alkyl or lower alkoxy), provided that when R.sup.1 is amino and R.sup.2 is hydrogen, Z cannot be represented by the formula (A), and their pharmaceutically acceptable acid addition salts, which are useful as psychotropic, neuroleptic or analgesic agents.

    摘要翻译: 其中R1是卤素,氨基,烷酰基氨基,烷基氨基或N-(烷酰基)烷基氨基的新颖的γ-哌啶基丁酰苯衍生物, R2是氢或卤素,条件是当R1是卤素时,R2必须是卤素; Z为具有式(A),(A)的哌啶子基,其中R a和R b各自为氢,卤素,低级烷基,低级烷氧基或三氟甲基; R 3为氢或羟基; n为1或 2)或具有式(B)的哌啶子基,其中R c是氢或低级烷基;并且R d和R e各自是氢,卤素,低级烷基或低级烷氧基),条件是当 R1是氨基,R2是氢,Z不能由式(A)表示,它们的药学上可接受的酸加成盐可用作精神药物,精神抑制剂或止痛剂。

    Cyclopropylmethylamine derivatives
    65.
    发明授权
    Cyclopropylmethylamine derivatives 失效
    环丙基甲胺衍生物

    公开(公告)号:US4110376A

    公开(公告)日:1978-08-29

    申请号:US605012

    申请日:1975-08-15

    CPC分类号: C07D401/12

    摘要: Novel cyclopropylmethylamine compounds of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are each hydrogen or halogen and R.sup.3 is hydrogen or methyl, and their non-toxic salts, which possess various useful pharmacological activities and can be produced by reduction of the corresponding compounds of the formula: ##STR2## wherein R.sup.1, R.sup.2 and R.sup.3 are each as defined above or their non-toxic salts, or by condensation of the corresponding compounds of the formula: ##STR3## wherein R.sup.1 and R.sup.2 are each defined above, and X is a conventional interchangeable group such as halogen or sulfonyloxy with methylamine or dimethylamine.

    摘要翻译: 下式的新型环丙基甲胺化合物:其中R 1和R 2各自为氢或卤素,R 3为氢或甲基,及其无毒盐,其具有各种有用的药理活性,可通过还原相应化合物 其中R 1,R 2和R 3各自如上所定义,或其无毒盐,或通过下式的相应化合物的缩合:其中R 1和R 2各自如上所定义,X为 常规的可互换基团如卤素或磺酰氧基与甲胺或二甲胺。

    Novel morpholine derivatives and the treatment of mental depression
    66.
    发明授权
    Novel morpholine derivatives and the treatment of mental depression 失效
    新型吗啉衍生物和精神抑郁症的治疗

    公开(公告)号:US4085210A

    公开(公告)日:1978-04-18

    申请号:US646908

    申请日:1976-01-06

    CPC分类号: C07D265/30 C07D267/10

    摘要: Novel morpholine compounds of the formula: ##STR1## wherein R.sub.1 represents hydrogen or C.sub.1 -C.sub.4 alkyl, R.sub.2 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.5 alkenyl, C.sub.3 -C.sub.5 alkynyl, aryl-(C.sub.1 -C.sub.4)alkyl, (C.sub.3 -C.sub.6)cycloalkyl(C.sub.1 -C.sub.4)alkyl, polyhalo(C.sub.2 -C.sub.4)alkyl or hydroxy(C.sub.2 -C.sub.4)alkyl, A represents straight or branched C.sub.2 -C.sub.4 alkylene, B represents a divalent radical selected from the group consisting of --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, ##STR2## --CH.sub.2 --O--, --CH.sub.2 --S--, --S-- and --O--, >D --E-- represents a trivalent radical selected from the group consisting of >CH--CH.sub.2 -- and >C.dbd.CH-- and C.sub.1 and C.sub.2 each represent 1,2-phenylene optionally substituted with one or more substituents selected from the group consisting of halogen, C.sub.1 -C.sub.4 alkyl and C.sub.1 -C.sub.4 alkoxy, and their non-toxic salts, which are useful as antidepressants and can be produced by various methods.

    摘要翻译: 式中:R1代表氢或C1-C4烷基,R2代表氢,C1-C4烷基,C3-C5烯基,C3-C5炔基,芳基 - (C1-C4)烷基,(C3 -C 6)环烷基(C 1 -C 4)烷基,多卤代(C 2 -C 4)烷基或羟基(C 2 -C 4)烷基,A表示直链或支链C 2 -C 4亚烷基,B表示选自-CH 2 -CH 2 - , - CH = CH-, -CH 2 -O-,-CH 2 -S-,-S-和-O-,> D-E-代表选自下组的三价基团:CH -CH 2 - 和> C = CH-且C 1和C 2各自表示任选被一个或多个选自卤素,C 1 -C 4烷基和C 1 -C 4烷氧基的取代基取代的1,2-亚苯基,它们的无毒 盐,其可用作抗抑郁药并且可以通过各种方法制备。

    Analgetic composition
    67.
    发明授权
    Analgetic composition 失效
    笔画组成

    公开(公告)号:US4083981A

    公开(公告)日:1978-04-11

    申请号:US773936

    申请日:1977-03-03

    摘要: An analgetic composition which comprises, as an active ingredient, a therapeutically effective amount of a synergistic mixture of an indole-3-acetic acid derivative of the formula, ##STR1## wherein R is a halobenzoyl, piperonylcyl or cinnamoyl group and R.sub.1 is a 5-methoxy or 5,6-methylenedioxy group; and a narcotic or anti-narcotic analgesic selected from the group consisting of a compound of the formula, ##STR2## wherein R.sub.2 and R.sub.3 are each a C.sub.1 - C.sub.3 alkyl group and R.sub.4 is a 4-(4-fluorophenyl)-4-oxobutyl, cyclopropylmethyl or 3-methyl-2-butenyl group; a compound of the formula, ##STR3## wherein R.sub.5 is a hydrogen atom or a C.sub.1 - C.sub.3 alkyl group; a compound of the formula, ##STR4## and a compound of the formula, ##STR5## wherein R.sub.6 is a C.sub.1 - C.sub.3 alkyl group; and a pharmaceutically acceptable carrier or diluent and its preparation and a method of obtaining analgesia which comprises administering the same to a patient.

    摘要翻译: 一种止痛组合物,其包含作为活性成分的治疗有效量的下式的吲哚-3-乙酸衍生物,其中R是卤代苯甲酰基,胡烷基或肉桂酰基的吲哚-3-乙酸衍生物,R 1为5 - 甲氧基或5,6-亚甲二氧基; 以及选自由下式化合物组成的组的麻醉或抗麻醉止痛剂,其中R2和R3各自为C1-C3烷基,R4为4-(4-氟苯基)-4-氧代丁基 ,环丙基甲基或3-甲基-2-丁烯基; 下式的化合物,其中R 5是氢原子或C 1 -C 3烷基; 下式的化合物和下式的化合物,其中R 6是C 1 -C 3烷基; 和药学上可接受的载体或稀释剂及其制备方法和获得镇痛的方法,其包括将其施用于患者。

    Novel n'-acylated phenyl-hydrazine and -hydrazone derivatives
    69.
    发明授权
    Novel n'-acylated phenyl-hydrazine and -hydrazone derivatives 失效
    新型n {40-酰基苯基 - 肼和腙衍生物

    公开(公告)号:US4060550A

    公开(公告)日:1977-11-29

    申请号:US651831

    申请日:1976-01-23

    摘要: Indolylacetic acid derivatives, which have excellent anti-inflammatory, antipyretic and analgesic activities, represented by the formula, ##STR1## wherein X.sub.1 and X.sub.2 are each methylene; A is an unsubstituted ethylenically unsaturated hydrocarbon chain having up to 5 carbon atoms; m is 0 or 1; n is 1 or 2; R.sub.3 is alkyl having up to 4 carbon atoms; cycloalkyl having 3 to 7 carbon atoms, unsubstituted or C.sub.1 -C.sub.4 alkyl-, nitro-, trifluoromethyl-, methylenedioxy-, ethylenedioxy- or halogen-substituted phenyl, or halogen-, C.sub.1 -C.sub.4 alkyl- or phenyl-substituted or benzene ring-condensed C.sub.3 -C.sub.7 cycloalkyl, or unsubstituted or halogen-, C.sub.1 -C.sub.4 alkyl- or phenyl-substituted or benzene ring-condensed C.sub.5 -C.sub.6 cycloalkenyl; and B is ##STR2## .

    摘要翻译: 吲哚乙酸衍生物,其具有优异的抗炎,解热和止痛活性,由下式表示,其中X1和X2各自为亚甲基; A是具有至多5个碳原子的未取代的烯属不饱和烃链; m为0或1; n为1或2; R3是具有至多4个碳原子的烷基; 具有3-7个碳原子的环烷基,未取代的或C 1 -C 4烷基 - ,硝基 - ,三氟甲基 - ,亚甲二氧基 - ,亚乙二氧基或卤素取代的苯基,或卤素 - ,C 1 -C 4烷基 - 或苯基取代的或苯环 - 或未取代的或卤素的,C 1 -C 4烷基或苯基取代的或苯环稠合的C 5 -C 6环烯基; 而B是

    Process for preparing 1,4-benzodiazepines
    70.
    发明授权
    Process for preparing 1,4-benzodiazepines 失效
    制备1,4-苯并二氮杂卓的方法

    公开(公告)号:US4044003A

    公开(公告)日:1977-08-23

    申请号:US598621

    申请日:1975-07-24

    IPC分类号: C07D243/16

    CPC分类号: C07D243/16

    摘要: 1,4-Benzodiazepine derivatives of the formula, ##STR1## wherein R.sub.1 is hydrogen, a lower alkyl, a haloalkyl, a cycloalkylalkyl, an alkoxyalkyl, an acyloxyalkyl, an alkylthioalkyl, an alkylaminoalkyl, a dialkylaminoalkyl, a hydroxyalkyl, carbamoyl, or an N-alkylcarbamoyl; R.sub.2 is hydrogen or a lower alkyl; X is hydrogen, a halogen, nitro, or trifluoromethyl; A is a group of the formula, ##STR2## (wherein Y and Z each represent hydrogen, a halogen, a lower alkyl, or nitro) and a salt thereof, are prepared by reacting a 1,4-benzodiazepin-2-one compound of the formula, ##STR3## wherein R.sub.1, R.sub.2, X, Y and Z are the same as defined above, with diborane in an inert solvent.

    摘要翻译: 其中R1是氢,低级烷基,卤代烷基,环烷基烷基,烷氧基烷基,酰氧基烷基,烷基硫代烷基,烷基氨基烷基,二烷基氨基烷基,羟基烷基,氨基甲酰基或 N-烷基氨基甲酰基; R2是氢或低级烷基; X是氢,卤素,硝基或三氟甲基; A是通过使1,4-苯并二氮杂-2-酮化合物(其中Y和Z各自表示氢,卤素,低级烷基或硝基)及其盐的式 其中R1,R2,X,Y和Z与上述定义相同,与乙硼烷在惰性溶剂中反应。